Kyntra Bio (KYNB) Interest Expenses (2014 - 2026)
Kyntra Bio (KYNB) posted Interest Expenses of $3.0 million for Q1 2026, up 9900.0% sequentially from $30000.0 in Q4 2025, and little changed YoY from $3.0 million in Q1 2025.
Kyntra Bio (KYNB) Interest Expenses (2014 - 2026) Analysis & Trends
Kyntra Bio has reported Interest Expenses for 13 years, with the latest figure at $3.0 million in Q1 2026.
- Quarterly Interest Expenses changed 0.0% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.1 million (down 57.25% YoY) and the FY2025 annual result came in at $8.8 million, down 45.96% from the prior year.
- Interest Expenses advanced to $3.0 million in Q1 2026 per KYNB's latest filing, from $30000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $15.2 million in Q4 2022 and troughed at $30000.0 in Q4 2025.
- A 5-year average of $4.0 million and a median of $3.0 million in 2025 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2022 and 2025: Interest Expenses jumped 13696.36% in 2022, then plunged 99.71% in 2025.
- Over 5 years, Interest Expenses stood at $15.2 million in 2022, then sank by 76.31% to $3.6 million in 2023, then jumped by 183.12% to $10.2 million in 2024, then slumped by 99.71% to $30000.0 in 2025, then soared by 9900.0% to $3.0 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $3.0 million, $30000.0, and $2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Kyntra Bio | 30.42 Mn | 30.42 Mn | 1.47 Mn | 2.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.37 Mn |
| Jun 30, 2026 | 2.37 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 30,000.00 |
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | 2.08 Mn |
| Sep 30, 2025 | 2.08 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 10.18 Mn |
| Dec 31, 2024 | 10.18 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 2.90 Mn |
| Mar 31, 2024 | 2.90 Mn |
| Mar 31, 2024 | 2.90 Mn |